MARKET IS CLOSED
Loading latest tickers...
Market Indices
S&P 500
$7,722.72
+0.73%
NASDAQ 100
$30,807.93
+1.00%
DOW JONES
$51,177.00
+0.49%
NASDAQ Composite
$27,190.86
+1.19%
RUSSELL 2000
$2,815.20
+0.90%
CBOE VIX
$15.31
-6.59%
Sector Heatmap
Technology+1.01%
Financials+0.06%
Healthcare-0.01%
Consumer Cycl+1.13%
Consumer Staples+0.25%
Energy+0.40%
Industrials+0.78%
Materials+0.66%
Real Estate+0.32%
Utilities+0.38%
Comm Services+0.35%
ARTV — Artiva Biotherapeutics, Inc. Common Stock
NasdaqArtiva Biotherapeutics, Inc. Common Stock
$6.83
+0.04(+0.59%)
- O
- 6.89
- H
- 7.00
- L
- 6.74
- V
- 587.44K
⏱️ End-of-day dataAs of Oct 2, 2026
ARTV — Financial Statements
Historical 2-Year Statements| Financial Metric / Line Item | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 |
|---|---|---|---|---|---|---|
| Fiscal Date | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-12-31 |
| Period | quarterly | quarterly | quarterly | quarterly | quarterly | quarterly |
| Year | 2,026.00 | 2,025.00 | 2,025.00 | 2,025.00 | 2,025.00 | 2,024.00 |
| Cash And Cash Equivalents | $20.95M | $26.70M | $25.51M | $28.47M | $30.40M | $40.23M |
| Other Short Term Investments | $65.83M | $81.31M | $97.46M | $11.39M | $13.56M | $14.52M |
| Other Current Assets | $1.96M | $4.59M | $6.48M | $6.67M | $3.81M | $3.06M |
| Total Current Assets | $88.74M | $11.27M | $12.95M | $14.91M | $17.00M | $18.86M |
| Properties | $22.82M | $23.24M | $23.71M | $24.64M | $25.35M | $24.45M |
| Machinery Furniture Equipment | $1.71M | $1.71M | $1.70M | $1.59M | $1.50M | $1.49M |
| Leases | 874,000.00 | 867,000.00 | 865,000.00 | 754,000.00 | 471,000.00 | 410,000.00 |
| Accumulated Depreciation | $-9.11M | $-8.46M | $-7.81M | $-7.16M | $-6.53M | $-5.92M |
| Other Non Current Assets | 919,000.00 | 919,000.00 | 879,000.00 | 499,000.00 | 474,000.00 | 525,000.00 |
| Total Non Current Assets | $17.21M | $18.27M | $19.34M | $20.32M | $21.26M | $20.95M |
| Total Assets | $10.60M | $13.09M | $14.89M | $16.94M | $19.13M | $20.96M |
| Accounts Payable | $2.29M | 355,000.00 | 848,000.00 | $1.22M | $2.04M | $1.12M |
| Accrued Expenses | $5.56M | $9.60M | $7.03M | $5.84M | $6.38M | $7.39M |
| Short Term Debt | $3.04M | $3.06M | $3.17M | $3.64M | $3.72M | $3.74M |
| Total Current Liabilities | $10.88M | $13.09M | $11.12M | $10.77M | $12.20M | $12.25M |
| Long Term Debt | $7.23M | $7.88M | $8.52M | $9.58M | $10.28M | $10.61M |
| Total Non Current Liabilities | $7.23M | $7.88M | $8.52M | $9.58M | $10.28M | $10.69M |
| Total Liabilities | $18.11M | $20.97M | $19.64M | $20.35M | $22.48M | $22.94M |
| Common Stock | 3,000.00 | 3,000.00 | 3,000.00 | 3,000.00 | 3,000.00 | 3,000.00 |
| Retained Earnings | $-35.41M | $-33.05M | $-30.98M | $-28.82M | $-26.70M | $-24.67M |
| Other Shareholders Equity | -18,000.00 | 103,000.00 | 87,000.00 | 2,000.00 | 0.00 | -129,000.00 |
| Total Shareholders Equity | $87.85M | $11.00M | $12.92M | $14.90M | $16.88M | $18.66M |
| Additional Paid In Capital | $44.19M | $44.04M | $43.89M | $43.73M | $43.58M | $43.35M |
| Other Receivables | N/A | 6,000.00 | 42,000.00 | N/A | 223,000.00 | 146,000.00 |
| Other Current Liabilities | N/A | 73,000.00 | 73,000.00 | 73,000.00 | 73,000.00 | N/A |
| Accounts Receivable | N/A | N/A | N/A | N/A | N/A | 0.00 |
| Derivative Product Liabilities | N/A | N/A | N/A | N/A | N/A | 0.00 |
| Other Non Current Liabilities | N/A | N/A | N/A | N/A | N/A | 73,000.00 |